Adipogen/anti-TLR8 (human), mAb (ABM15F6)/AG-20T-0307-C100/100 ?g
一抗
商品編號
AG-20T-0307-C100
品牌
Adipogen
公司
Adipogen
公司分類(lèi)
Antibodies
Size
100 ?g
商品信息
More Information
Product Details
Synonyms
Toll-like Receptor 8; CD288
Product Type
Monoclonal Antibody
Properties
Clone
ABM15F6
Isotype
Mouse IgG1κ
Immunogen/Antigen
Recombinant human TLR8 protein (aa 750-900).
Application
Flow Cytometry:
(0.5-2μg/10
6
cells)
Immunohistochemistry:
(5μg/ml; paraffin sections)
Optimal conditions must be determined individually for each application.
Crossreactivity
Human
Specificity
Recognizes human TLR8.
Purity
Protein G purified.
Concentration
0.5mg/ml
Formulation
Liquid. In PBS containing 0.05% BSA and 0.05% sodium azide.
Declaration
Q9NR97
Shipping and Handling
Shipping
BLUE ICE
Short Term Storage
+4°C
Long Term Storage
-20°C
Handling Advice
After opening, prepare aliquots and store at -20°C.
Avoid freeze/thaw cycles.
Use/St
ABI
lity
Stable for at least 1 year after receipt when stored at -20°C.
Stable for at least 6 months after receipt when stored at +4°C.
Documents
MSD
S
No
Product Specification Sheet
Datasheet
Download PDF
TLR8 (Toll-like Receptor 8) is a member of the TLR (Toll-like receptor) family that plays a fundamental role in pathogen recognition and activation of innate immunity. TLR8 is a nucleotide-sensing TLR. TLR8 and TLR7 recognize single-stranded RNA (ssRNA) sequences containing GU-rich or poly-U sequences as their natural ligands, and they are also activated by synthetic small-molecular-weight compounds of the imidazoquinoline family. Both TLR8 and TLR7 signal via MYD88 and TRAF6, le
ADI
ng to NF-κB and antiviral factor, such as IRF family activation, cytokine secretion and the inflammatory response. They are localized intracellularly to endosomal membranes and act as potent activators of innate immune responses upon viral infection. The TLR8 gene is predominantly expressed in lung and peripheral blood leukocytes and lies in close proximity to TLR7 on chromosome X. Genetic variants in TLR8 have been linked to susceptibility to pulmonary tuberculosis. Recently, small molecule TLR7/8 ago
NIST
s have demonstrated potential as vaccine adjuvants, since they directly activate antigen-presenting cells (APCs) and can enhance both humoral and cellular immune responses, especially Th1 responses. This makes the TLR7/8 signaling pathways interesting therapeutic targets.
產(chǎn)品貨號:3932.0